Evidence map›Paper›PMID 35743695›Full record

ArticleJournal of personalized medicine2022

Emotional Reaction to the First Dose of COVID-19 Vaccine: Postvaccination Decline in Anxiety and Stress among Anxious Individuals and Increase among Individuals with Normal Prevaccination Anxiety Levels.

Rasmieh Al-Amer, Malakeh Z Malak, Hala Mohammad Ramadan Burqan, Elena Stănculescu, Sylivia Nalubega, Abdulmajeed A Alkhamees, Amin Omar Hendawy, Amira Mohammed Ali

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 6 countries.

Rasmieh Al-AmerFaculty of Nursing, Isra University, Amman 11953, Jordan.ORCID 0000-0002-9411-7386
Malakeh Z MalakCommunity Health Nursing, Faculty of Nursing, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.ORCID 0000-0002-2412-2999
Hala Mohammad Ramadan BurqanSchool of Nursing, Alghad International Colleges for Applied Medical Sciences, Riyadh Branch, Riyadh 13315, Saudi Arabia.
Elena StănculescuFaculty of Psychology and Educational Sciences, University of Bucharest, 050663 Bucharest, Romania.ORCID 0000-0002-3912-812X
Sylivia NalubegaDepartment of Nursing, School of Health Sciences, Soroti University, Soroti City 211, Uganda.
Abdulmajeed A AlkhameesDepartment of Medicine, Unayzah College of Medicine and Medical Sciences, Qassim University, Unayzah 52571, Saudi Arabia.ORCID 0000-0003-2808-2370
Amin Omar HendawyDepartment of Animal and Poultry Production, Faculty of Agriculture, Damanhour University, Damanhour 22516, Egypt.ORCID 0000-0002-4325-978X
Amira Mohammed AliDepartment of Psychiatric Nursing and Mental Health, Faculty of Nursing, Alexandria University, Smouha, Alexandria 21527, Egypt.ORCID 0000-0002-6448-8282
Alexandria University · EGAl-Ghad International Health Sciences Colleges · SAAl-Zaytoonah University of Jordan · JODamanhour University · EGQassim University · SASoroti University · UGUniversity of Bucharest · ROWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although vaccination has been adopted by the WHO to limit worldwide transmission of COVID-19, people's worries about COVID-19 vaccines may suppress their desire for vaccination despite vaccine availability. This study aimed to investigate anxiety and stress symptoms among 250 Jordanians (mean age = 43.18 ± 6.34 years, 72% females) who received their first vaccine dose. The respondents completed the anxiety and stress subscales of the Depression Anxiety and Stress scale 21 (DASS-21) before and after vaccination. The respondents expressed more moderate-severe levels of stress before than after vaccination (20.8% and 13.2%, respectively). Meanwhile, 37.2% and 45.2% of the respondents expressed moderate-severe anxiety before and after vaccination, respectively. Wilcoxon signed-rank test revealed that the drop in the level of stress from before- (median (IQR) = 5 (1-8)) to after vaccination (median (IQR) = 3 (1-7)) was statistically significant (z = -3.81,

Indexed as

anxietyCOVID-19hesitancyJordan/Arabpreparednessstressvaccine/vaccination

Identifiers

PMID35743695
PMCPMC9224616
OpenAlexW4281684280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.